1046 related articles for article (PubMed ID: 8098137)
41. Glial cell line-derived neurotrophic factor attenuates the locomotor hypofunction and striatonigral neurochemical deficits induced by chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid.
Araujo DM; Hilt DC
Neuroscience; 1998 Jan; 82(1):117-27. PubMed ID: 9483508
[TBL] [Abstract][Full Text] [Related]
42. Reconstruction of the nigrostriatal pathway by simultaneous intrastriatal and intranigral dopaminergic transplants.
Mendez I; Sadi D; Hong M
J Neurosci; 1996 Nov; 16(22):7216-27. PubMed ID: 8929430
[TBL] [Abstract][Full Text] [Related]
43. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--III. Reversal by embryonic nigral dopamine grafts.
Sirinathsinghji DJ; Dunnett SB; Northrop AJ; Morris BJ
Neuroscience; 1990; 37(3):757-66. PubMed ID: 2247221
[TBL] [Abstract][Full Text] [Related]
44. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
Sanchez B; Relova JL; Gallego R; Ben-Batalla I; Perez-Fernandez R
J Neurosci Res; 2009 Feb; 87(3):723-32. PubMed ID: 18816795
[TBL] [Abstract][Full Text] [Related]
45. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
Costall B; Marsden CD; Naylor RJ; Pycock CJ
Brain Res; 1976 Dec; 118(1):87-113. PubMed ID: 990957
[TBL] [Abstract][Full Text] [Related]
46. Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo.
Hoffer BJ; Hoffman A; Bowenkamp K; Huettl P; Hudson J; Martin D; Lin LF; Gerhardt GA
Neurosci Lett; 1994 Nov; 182(1):107-11. PubMed ID: 7891873
[TBL] [Abstract][Full Text] [Related]
47. GDNF reverses priming for dyskinesia in MPTP-treated, L-DOPA-primed common marmosets.
Iravani MM; Costa S; Jackson MJ; Tel BC; Cannizzaro C; Pearce RK; Jenner P
Eur J Neurosci; 2001 Feb; 13(3):597-608. PubMed ID: 11168568
[TBL] [Abstract][Full Text] [Related]
48. Increases in [3H]FK-506 and [3H]L-N(G)-nitro-arginine binding in the rat brain after nigrostriatal dopaminergic denervation.
Araki T; Tanji H; Fujihara K; Kato H; Itoyama Y
Metab Brain Dis; 1999 Mar; 14(1):21-31. PubMed ID: 10348311
[TBL] [Abstract][Full Text] [Related]
49. Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo.
Strömberg I; Björklund L; Johansson M; Tomac A; Collins F; Olson L; Hoffer B; Humpel C
Exp Neurol; 1993 Dec; 124(2):401-12. PubMed ID: 7904571
[TBL] [Abstract][Full Text] [Related]
50. Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat.
Connor B; Kozlowski DA; Schallert T; Tillerson JL; Davidson BL; Bohn MC
Gene Ther; 1999 Dec; 6(12):1936-51. PubMed ID: 10637445
[TBL] [Abstract][Full Text] [Related]
51. The influence of acute and chronic administration of 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline on the function of the nigrostriatal dopaminergic system in rats.
Lorenc-Koci E; Antkiewicz-Michaluk L; Kamińska A; Lenda T; Zieba B; Wierońska J; Smiałowska M; Schulze G; Rommelspacher H
Neuroscience; 2008 Oct; 156(4):973-86. PubMed ID: 18809471
[TBL] [Abstract][Full Text] [Related]
52. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.
Kozlowski DA; Connor B; Tillerson JL; Schallert T; Bohn MC
Exp Neurol; 2000 Nov; 166(1):1-15. PubMed ID: 11031079
[TBL] [Abstract][Full Text] [Related]
53. Immunohistochemical and neurochemical studies on nigral and striatal functions in the circling (ci) rat, a genetic animal model with spontaneous rotational behavior.
Richter A; Ebert U; Nobrega JN; Vallbacka JJ; Fedrowitz M; Löscher W
Neuroscience; 1999 Mar; 89(2):461-71. PubMed ID: 10077328
[TBL] [Abstract][Full Text] [Related]
54. Oxytocin-conjugated saporin injected into the substantia nigra of male rats alters the activity of the nigrostriatal dopaminergic system: A behavioral and neurochemical study.
Sanna F; Bratzu J; Angioni L; Pina Sorighe M; Cocco C; Argiolas A; Melis MR
Brain Res; 2021 Dec; 1773():147705. PubMed ID: 34744015
[TBL] [Abstract][Full Text] [Related]
55. Glial cell line-derived neurotrophic factor induces the dopaminergic and cholinergic phenotype and increases locomotor activity in aged Fischer 344 rats.
Lapchak PA; Miller PJ; Jiao S
Neuroscience; 1997 Apr; 77(3):745-52. PubMed ID: 9070749
[TBL] [Abstract][Full Text] [Related]
56. Time course of striatal changes induced by 6-hydroxydopamine lesion of the nigrostriatal pathway, as studied by combined evaluation of rotational behaviour and striatal Fos expression.
Labandeira-Garcia JL; Rozas G; Lopez-Martin E; Liste I; Guerra MJ
Exp Brain Res; 1996 Feb; 108(1):69-84. PubMed ID: 8721156
[TBL] [Abstract][Full Text] [Related]
57. Axonal transport of proteins and glycoproteins in the rat nigro-striatal pathway and the effects of 6-hydroxydopamine.
Roger LJ; Breese GR; Morell P
Brain Res; 1980 Sep; 197(1):95-112. PubMed ID: 6156743
[TBL] [Abstract][Full Text] [Related]
58. Brain-derived neurotrophic factor and neurotrophin-3 activate striatal dopamine and serotonin metabolism and related behaviors: interactions with amphetamine.
Martin-Iverson MT; Todd KG; Altar CA
J Neurosci; 1994 Mar; 14(3 Pt 1):1262-70. PubMed ID: 8074747
[TBL] [Abstract][Full Text] [Related]
59. Effects of donor age and brain-derived neurotrophic factor on the survival of dopaminergic neurons and axonal growth in postnatal rat nigrostriatal cocultures.
Ostergaard K; Jones SA; Hyman C; Zimmer J
Exp Neurol; 1996 Dec; 142(2):340-50. PubMed ID: 8934565
[TBL] [Abstract][Full Text] [Related]
60. Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon.
Hyman C; Juhasz M; Jackson C; Wright P; Ip NY; Lindsay RM
J Neurosci; 1994 Jan; 14(1):335-47. PubMed ID: 8283241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
